Screener
First Tracks Biotherapeutics Inc TRAX Short-Term Investments
Short-Term Investments at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $248,469 | $238,196 |
| Short-term investments | 37,986 | 73,442 |
| Prepaid expenses and other current assets | 2,947 | 4,762 |
| Total current assets | 289,402 | 316,400 |
| Property and equipment, net | 1,174 | 1,370 |
| Operating lease right-of-use assets | — | 12,519 |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's short-term investments?
- First Tracks Biotherapeutics Inc (TRAX) reported short-term investments of $37.99M in Q1 2026.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about First Tracks Biotherapeutics Inc's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude